Inflammation in atherosclerosis and acute coronary syndromes

Ross, 1999, Atherosclerosis—an inflammatory disease, N. Engl. J. Med., 340, 115, 10.1056/NEJM199901143400207 Astrup, 1959, Role of coagulation and fibrinolysis in the pathogenesis of arteriosclerosis, 223 Astrup, 1956, Fibrinolysis in the organism, Blood, 11, 781, 10.1182/blood.V11.9.781.781 Astrup, 1966, Tissue activators of plasminogen, Fed. Proc., 25, 42 Kragel, 1989, Morphometric analysis of the components of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death, Circulation, 80, 1747, 10.1161/01.CIR.80.6.1747 Zhou, 1999, Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes, Scand. J. Clin. Lab. Invest., 230, 3, 10.3109/00365519909168321 Moreno, 1994, Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture, Circulation, 90, 775, 10.1161/01.CIR.90.2.775 Lendon, 1991, Atherosclerotic plaque caps are locally weakened when macrophages density is increased, Atherosclerosis, 87, 87, 10.1016/0021-9150(91)90235-U Ross, 1993, The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature, 362, 801, 10.1038/362801a0 Sewell, 1993, Pathogenesis of rheumatoid arthritis, Lancet, 341, 283, 10.1016/0140-6736(93)92627-6 Pasceri, 1999, A tail of two diseases. Atherosclerosis and rheumatoid arthritis, Circulation, 100, 2124, 10.1161/01.CIR.100.21.2124 Wållberg-Johnsson, 1997, Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden, J. Rheumatol., 24, 345 Wållberg-Johnsson, 1999, Extent of inflammation predicts cardiovascular disease and over all mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset, J. Rheumatol., 26, 2562 Gram, 2000, Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control study, J. Intern. Med., 247, 205, 10.1046/j.1365-2796.2000.00604.x Kuller, 1996, Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study, Am. J. Epidemiol., 144, 537, 10.1093/oxfordjournals.aje.a008963 Tracy, 1996, C-reactive protein and incidence of cardiovascular disease in older women: the rural health promotion project and the cardiovascular health study, Circulation, 93, 622 Koenig, 1999, C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men, Circulation, 99, 237, 10.1161/01.CIR.99.2.237 Ridker, 1997, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N. Engl. J. Med., 336, 973, 10.1056/NEJM199704033361401 Ridker, 1998, Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women, Circulation, 98, 731, 10.1161/01.CIR.98.8.731 Ridker, 2000, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease, N. Engl. J. Med., 342, 836, 10.1056/NEJM200003233421202 Thompson, 1995, Hemostatic factors and risk of myocardial infarction or sudden death in patients with angina pectoris, N. Engl. J. Med., 332, 635, 10.1056/NEJM199503093321003 Haverkate, 1997, Production of C-reactive protein and risk of coronary events in stable and unstable angina, Lancet, 349, 462, 10.1016/S0140-6736(96)07591-5 Danesh, 1998, Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. Meta-analyses of prospective studies, J. Am. Med. Assoc., 279, 1477, 10.1001/jama.279.18.1477 Forrester, 1987, A perspective of coronary disease seen through the arteries of living man, Circulation, 75, 505, 10.1161/01.CIR.75.3.505 Biasucci, 1999, Role of inflammation in the pathogenesis of unstable coronary plaques, Scand. J. Clin. Lab. Invest., 230, 12, 10.3109/00365519909168322 Toss, 1997, Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease, Circulation, 96, 4204, 10.1161/01.CIR.96.12.4204 Lindahl, 2000, Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease, N. Eng. J. Med., 343, 1139, 10.1056/NEJM200010193431602 Liuzzo, 1994, The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina, N. Engl. J. Med., 331, 417, 10.1056/NEJM199408183310701 Rothwell, 2000, Evidence of a chronic systemic cause of instability of atherosclerotic plaques, Lancet, 355, 19, 10.1016/S0140-6736(99)04470-0 Ford, 1998, Serum C-reactive protein and self-reported stroke. Findings from the third national health and nutrition examination survey, Arterioscler., Thromb., Vasc. Biol., 1052 Tracy, 1997, Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects, Arterioscler., Thromb., Vasc. Biol., 17, 2167, 10.1161/01.ATV.17.10.2167 Juhan-Vague, 1996, Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris, Circulation, 94, 2057, 10.1161/01.CIR.94.9.2057 Cermak, 1993, C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor, Blood, 82, 513, 10.1182/blood.V82.2.513.513 Wolbink, 1998, Complement activation in patients with sepsis is in part mediated by C-reactive protein, J. Infect. Dis., 177, 81, 10.1086/513803 Zouki, 1997, Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of l-selectin by C-reactive protein and peptides derived from C-reactive protein, J. Clin. Invest., 100, 522, 10.1172/JCI119561 Danesh, 1997, Chronic infections and coronary heart disease: is there a link, Lancet, 350, 430, 10.1016/S0140-6736(97)03079-1 Hak, 1999, Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women, Arterioscler., Thromb., Vasc. Biol., 19, 1986, 10.1161/01.ATV.19.8.1986 Ridker, 1999, Evaluation novel cardiovascular risk factors: can we better predict heart attacks?, Ann. Intern. Med., 130, 933, 10.7326/0003-4819-130-11-199906010-00018 Ridker, 1998, Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent event (CARE) investigators, Circulation, 98, 839, 10.1161/01.CIR.98.9.839